Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576797 · ClinicalTrials.gov registry record
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
A clinical trial of Healthy, sponsored by Emory University.
- Completed
- Registry status
- 396
- Enrollment target
- 3
- Study locations
NCT00576797: Completed study of Healthy, sponsored by Emory University.
NCT00576797 is a study of Healthy that has completed, run by Emory University. The registered enrollment target is 396 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (39% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00576797, a study of Healthy, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 396 participants
- Enrollment target
- 3
- Study locations
Study Summary
The human vagina contains a large number of normal bacteria. These bacteria are important because provide protection against other bacteria that may cause disease. Several important diseases are linked to abnormal bacteria in the vagina. Women with abnormal bacteria in the vagina are more likely to be infected with human immunodeficiency virus, the virus that causes AIDS. Also women with unusual bacteria in their vagina are more likely to deliver a premature baby when they are pregnant. For these reasons, it is important to have a better understanding of the normal bacteria of the vagina.Some bacteria found in the vagina can not be grown in a laboratory. Our preliminary studies indicate a very wide variety of bacteria in the vagina. Also we have shown there are some differences between African American and Caucasian women. The goal of our study is to study the bacteria in the vagina of normal women using the latest technology. This technology involves study the bacterial DNA present in the normal microbes in the vagina
Conditions Studied
Study Locations (3)
Maryland
- Adolescent and Young Adult Center (AYAC),UMB - Baltimore
- Center for Vaccine Development, University of Maryland - Baltimore
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-01 |
What the finished NCT00576797 record still lists
NCT00576797 is an observational study that tracks outcomes without assigning an intervention. The registered 396 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT00576797 reports a single indexed study location in Maryland, Georgia.
Frequently Asked Questions
What is clinical trial NCT00576797 about?
NCT00576797 is a clinical study titled "Genomic Tools for Studying the Ecology of the Human Vaginal Microflora". The human vagina contains a large number of normal bacteria. These bacteria are important because provide protection against other bacteria that may cause disease. Several important diseases are linked to abnormal bacteria in the vagina. Women with abnormal bacteria in the vagina are more likely to ...
What is the current status of trial NCT00576797?
This trial is currently completed. The enrollment target is 396 participants. The study started on 2008-05. Estimated completion is 2009-01.
What conditions does trial NCT00576797 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT00576797?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00576797 being conducted?
This trial has 3 study locations across Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00576797's enrollment target sits among peer trials
396 66th of 1090 higher than 1,025 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06227910 · 396 participants · Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- NCT06545331 · 396 participants · Phase 1
Study of XB010 in Subjects With Solid Tumors
- NCT06666790 · 396 participants · NA
DermaSensor Postmarket Surveillance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia